US FDA Issues Guidance on Postmarket Management of Cybersecurity in Medical Devices
The US Food and Drug Administration (FDA) has published guidance informing of the FDA’s recommendations for managing postmarket cybersecurity vulnerabilities for marketed and distributed medical devices. The guidance emphasizes that manufacturers of medical devices should monitor, identify, and address cybersecurity vulnerabilities and exploits as part of their postmarket management. It urges manufacturers to implement comprehensive cybersecurity risk management programs and ...
